BOSTON SCIENTIFIC CORPORATION Business Combination, Contingent Consideration, Liability
BOSTON SCIENTIFIC CORPORATION (BSX) had Business Combination, Contingent Consideration, Liability of $257.00 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2026-08-03
- 2026-06-30: Business Combination, Contingent Consideration, Liability $257.00M.
- 2026-03-31: Business Combination, Contingent Consideration, Liability $354.00M.
- 2025-12-31: Business Combination, Contingent Consideration, Liability $385.00M.
- 2025-09-30: Business Combination, Contingent Consideration, Liability $378.00M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2026-06-30 | $257.00M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $354.00M 10-Q · filed 2026-05-01 |
| 2025-12-31 | $385.00M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $378.00M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $367.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $214.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $171.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $171.00M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $293.00M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $273.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $404.00M 10-K · filed 2026-02-17 |
| 2023-09-30 | $119.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $107.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $93.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $149.00M 10-K · filed 2025-02-18 |
| 2022-09-30 | $182.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $219.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $456.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $486.00M 10-K · filed 2024-02-20 |
| 2021-09-30 | $448.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $312.00M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $398.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $196.00M 10-K · filed 2023-02-23 |
| 2020-09-30 | $214.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $208.00M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $218.00M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $354.00M 10-K · filed 2022-02-23 |
| 2019-09-30 | $380.00M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $394.00M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $394.00M 10-Q · filed 2019-04-29 |
| 2018-12-31 | $347.00M 10-K · filed 2021-02-23 |
| 2018-09-30 | $305.00M 10-Q · filed 2018-10-29 |
| 2018-06-30 | $279.00M 10-Q · filed 2018-07-31 |
| 2017-12-31 | $169.00M 10-Q · filed 2018-10-29 |
| 2013-11-01 | $0.00 10-K · filed 2015-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |